Destiny: Destiny Pharma to present data on its lead drug, Exeporfinium chloride at IPS Society conference on Sept 2325, 2024 in Birmingham
Destiny Pharma, a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life threatening infections, announced that new data on its lead drug,
Read full article »
Destiny Pharma is an England-based biotechnology company that researches and develops novel anti-infective therapies for the treatment of infectious diseases.
Read more